1. Home
  2. LXFR vs YDES Comparison

LXFR vs YDES Comparison

Compare LXFR & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Luxfer Holdings PLC

LXFR

Luxfer Holdings PLC

HOLD

Current Price

$17.23

Market Cap

459.5M

Sector

Industrials

ML Signal

HOLD

YDES

YD Bio Limited Ordinary Shares

N/A

Current Price

$5.79

Market Cap

543.0M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
LXFR
YDES
Founded
1898
2013
Country
United States
Taiwan
Employees
N/A
N/A
Industry
Major Chemicals
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
459.5M
543.0M
IPO Year
2002
2024

Fundamental Metrics

Financial Performance
Metric
LXFR
YDES
Price
$17.23
$5.79
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
390.0K
★ 607.2K
Earning Date
10-27-2026
08-31-2026
Dividend Yield
★ 3.02%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 0.31
N/A
Revenue
★ $384,600,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$6.26
N/A
P/E Ratio
$55.63
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$11.26
$1.70
52 Week High
$19.45
$22.00

Technical Indicators

Market Signals
Indicator
LXFR
YDES
Relative Strength Index (RSI) 52.14 56.50
Support Level $17.19 $2.33
Resistance Level $17.38 $9.11
Average True Range (ATR) 0.05 1.13
MACD -0.01 0.08
Stochastic Oscillator 31.32 59.60

Price Performance

Historical Comparison
LXFR
YDES

About LXFR Luxfer Holdings PLC

Luxfer Holdings PLC is engaged in materials engineering and the manufacture of materials, components, and gas containment products. The company has two reportable segments: Elektron and Gas Cylinders. The Elektron segment produces specialty materials based on magnesium and zirconium for applications in aerospace, defense, automotive, and industrial markets. The Gas Cylinders segment manufactures high-pressure gas containment products using aluminum alloys and carbon composite technologies for use in healthcare, emergency response, aerospace, and alternative fuel transportation markets.

About YDES YD Bio Limited Ordinary Shares

YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.

Share on Social Networks: